Company: BIAF
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001641172-25-025247
Chunk: 52

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-22
Form: DRS
Chunk 52
---
, superseded or replaced for purposes of this prospectus to the extent that a statement contained in this prospectus modifies, supersedes or replaces such statement. Any statement contained herein or in any document incorporated or deemed to be incorporated by reference shall be deemed to be modified or superseded for purposes of the registration statement of which this prospectus forms a part to the extent that a statement contained in any other subsequently filed document which also is or is deemed to be incorporated by reference modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed to constitute a part of the registration statement of which this prospectus forms a part, except as so modified or superseded.

| 31 |

<div align='center'>bioAffinity Technologies, Inc.

Up to [●] Shares of Common Stock

Up to [●] August 2025 Warrants to Purchase Shares of Common Stock

Up to [●] Pre-Funded Warrants to Purchase Shares of Common Stock

Placement Agent Warrants to Purchase up to [●] Shares of Common Stock

Up to [●] Shares of Common Stock Underlying the August 2025 Warrants,

Pre-Funded Warrants and Placement Agent Warrants

PROSPECTUS

, 2025.</div>

<div align='center'>PART II - INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 13. Other Expenses of Issuance and Distribution.

The following table sets forth an estimate of the fees and expenses relating to the issuance and distribution of the securities being registered hereby, other than underwriting discounts and commissions, all of which shall be borne by the registrant. All of such fees and expenses, except for the SEC registration fee and FINRA filing fee, are estimated:

| SEC registration fee                           |     | $ |
| FINRA filing fee                               |     |   |
| Transfer agent and registrar fees and expenses |     | $ |
| Legal fees and expenses                        |     | $ |
| Printing fees and expenses                     |     | $ |
| Accounting fees and expenses                   |     | $ |
| Miscellaneous fees and expenses                |     | $ |
| Total                                          |     | $ |

Item 14. Indemnification of Officers and Directors.

bioAffinity Technologies, Inc. is incorporated under the laws of the State of Delaware. Reference is made to Section 102(b)(7) of the DGCL, which enables a corporation in its original certificate of incorporation or an amendment thereto to eliminate or limit the personal liability